Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2018 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

Report in Current Biology by Lie-Jensen and Haglund:Parallels between ALIX recruitment during cytokinetic abscission in flies and virus budding in human cells

Anette Lie-Jensen (left) and Kaisa Haglund
Anette Lie-Jensen (left) and Kaisa Haglund

Understanding how abscission between daughter cells during the final stage of cell division, cytokinesis, is accurately controlled is relevant for cancer, because failure in this process may give rise to binucleate cells and in the next cell division chromosomal missegregation, which might cause aneuploidy, a common feature of cancer cells.  In a recent issue of Current Biology, Lie-Jensen and co-authors elucidate a mechanism by which the abscission machinery is recruited to the midbody in the fruit fly Drosophila melanogaster during abscission.

HIV research performed by Jan Terje Andersen's group presented in Aftenposten

Jan Terje Andersen
Jan Terje Andersen

The major national Norwegian newspaper Aftenposten has recently presented the research of Jan Terje Andersen's "Laboratory of Adaptive Immunity and Homeostasis" group in a feature article entitled "Antistoffer may lead to new HIV medicine.

The goal is a brand new long-acting, preventive HIV medicine that is adapted to the most vulnerable among us.

The Innovative science 2019 award-winning LUMIBLAST concept: Fighting brain cancer through photodynamic therapy, using light from within

Theodossis Theodossiou (left) and Kristian Berg
Theodossis Theodossiou (left) and Kristian Berg

Recently Oslo University Hospital was awarded by the European Commission the first prize for best innovative science 2019, for the inception of the idea of the ongoing Future and Emerging Technologies Open project: LUMIBLAST, coordinated by Kristian Berg and Theodossis Theodossiou.

Units and subpages

View all subunitsHide all subunits